Competent Cells Market is poised to value over USD 2.6 billion by 2027 end with a CAGR of over 10% during the forecast period 2020 to 2027.

The rising demand for molecular cloned products and recombinant proteins, technological advancements in research for molecular cloning and different initiatives undertaken by the government with the assignment of funds for researches conducted in life science sector are some of the major factors contributing to the growth of the market. Furthermore, favourable reimbursement policies have helped in the proliferation of the market. Conversely, high research costs shall impede the competent cells market growth. 
Component cells are Escherichia coli cells that have altered cells walls which can help in assimilating foreign DNA. These walls are made permeable using calcium chloride at zero degree Celsius and then heating at over 47 degree Celsius immediately for over 90 seconds. This treatment of calcium chloride helps in neutralising the repulsive action of phospholipid heads that are present in the membrane and heating causes thermal gradience which helps n creating a space for the DNA to enter the cell. These competent cells are mainly used for protein expressions and cloning applications. They react to environmental changes and DNA uptake released by the bacterial cells resulting in the induction of an organic process of transformation.   

Competent Cells Market

Market Segmentation:

By Product Type
•    Chemically Competent Cells  
•    Electrocompetent Cells     
By Application
•    Protein Expression
•    Cloning 
•    Others
By End User
•    Contract Research Organizations 
•    Academic Research Institutes
•    Pharmaceutical and Biotechnology Companies         
By Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

The market is fragmented into product type, end user, application and region. The product type segment is classified into chemically competent cells and electrocompetent cells. The chemically competent cells are predicted to hold the largest competent cells market share during the forecast period. The electrocompetent cells, however, are anticipated to grow at a substantial rate as they provide an efficient transformation, thereby making them the right choice for applications related to molecular biology like cDNA library generation or the construction of gene banks. The application segment is categorised into protein expression, cloning and others. The cloning segment is anticipated to lead the market, and this can be attributed to an increased cloning research by government bodies with the provision of infrastructure as well as the required funds. The end user segment is bifurcated into contract research organizations, academic research institutes and pharmaceutical and biotech companies. The pharmaceutical and biotech companies are anticipated to experience a substantial growth during the forecasted timeframe, and this can be credited to the increased investments in research activities related to the development of products that are based on proteomics and genomics.

Regional Analysis:

The North America region is predicted to dominate the market owing to increase in the research activities related to recombinant therapy with the rising need for recombinant products on a commercial basis. Furthermore, an extensive research has been conducted in the field of protein cloning by key players present in the region. For instance, Thermo Fisher Scientific use E. coli strands of the DH5 alpha family for routing protein cloning which provide them with an efficient outcome of over 1*10^9 cfu/microgram. 

Competitive Landscape:                            

Some of the key market players associated are Thermo Fisher Scientific Inc., Merck KGaA, New England Biolabs, Takara Bio Inc., Promega Corporation, GenScript Biotech Corporation, Agilent Technologies Inc. 

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global competent cells market by product type, by application, by end user and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions    

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com


Need Assistance


UK : +44 141 628 9353
US : +1 347 709 4931


Contact Sales

What you get

  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included

  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics